Statistics for Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review
Total visits
| views | |
|---|---|
| Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review | 44 |
Total visits per month
| views | |
|---|---|
| December 2024 | 8 |
| January 2025 | 1 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19_a scoping review.pdf(legacy) | 18 |
| null(legacy) | 5 |
| Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19_a scoping review.pdf | 2 |
| DanielaCarvalho_45052_MEQB.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 22 |
| China | 8 |
| Singapore | 3 |
| India | 2 |
| Portugal | 2 |
| Brazil | 1 |
| Hungary | 1 |
| Israel | 1 |
| Mongolia | 1 |
| Mexico | 1 |
| Pakistan | 1 |
| Ukraine | 1 |